Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phospho-FGFR1 Positive Control | Login | Phospho-FGFR1 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Phospho-FGFR2 Positive Control | Login | Phospho-FGFR2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Phospho-ErbB 2 Positive Control | Login | Phospho-ErbB 2 Positive Control | ||||||||||||||||
|
||||||||||||||||||
Phospho-PDE4D ERK site Positive Control | Login | Phospho-PDE4D ERK site Positive Control | ||||||||||||||||
|
||||||||||||||||||
TNFAIP3 Blocking Peptide | Login | TNFAIP3 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
ABL1 Blocking Peptide | Login | ABL1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
CCDC98 Blocking Peptide | Login | CCDC98 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
CCDC98 Blocking Peptide | Login | CCDC98 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Atypical Chemokine Receptor D6 Blocking Peptide | Login | Atypical Chemokine Receptor D6 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Atypical Chemokine Receptor D6 Blocking Peptide | Login | Atypical Chemokine Receptor D6 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Adiponectin Blocking Peptide | Login | Adiponectin Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Annexin A1 Blocking Peptide | Login | Annexin A1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Aquaporin 1 Blocking Peptide | Login | Aquaporin 1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Bcl-XL Blocking Peptide | Login | Bcl-XL Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
B-raf Blocking Peptide | Login | B-raf Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Bone marrow stromal cell antigen 1 Blocking Peptide | Login | Bone marrow stromal cell antigen 1 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
Galectin 3 Blocking Peptide | Login | Galectin 3 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
DARPP32 Blocking Peptide | Login | DARPP32 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TdT Blocking Peptide | Login | TdT Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TdT Blocking Peptide | Login | TdT Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TIE2 Blocking Peptide | Login | TIE2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TIE2 Blocking Peptide | Login | TIE2 Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TMEM16A Blocking Peptide | Login | TMEM16A Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TMEM16A Blocking Peptide | Login | TMEM16A Blocking Peptide | ||||||||||||||||
|
||||||||||||||||||
TrkA Blocking Peptide | Login | TrkA Blocking Peptide | ||||||||||||||||
|